1
|
Abdullahi IN, Emeribe AU, Ghamba PE, Omosigho PO, Bello ZM, Oderinde BS, Fasogbon SA, Olayemi L, Daneji IM, Musa MH, Nwofe JO, Onukegbe NB, Okume CC, Musa S, Gwarzo AM, Ajagbe OOR. Distribution pattern and prevalence of West Nile virus infection in Nigeria from 1950 to 2020: a systematic review. Epidemiol Health 2020; 42:e2020071. [PMID: 33254358 PMCID: PMC8137371 DOI: 10.4178/epih.e2020071] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Accepted: 11/26/2020] [Indexed: 12/11/2022] Open
Abstract
OBJECTIVES West Nile virus (WNV) is a re-emerging mosquito-borne viral infection. This study investigated the pooled prevalence pattern and risk factors of WNV infection among humans and animals in Nigeria. METHODS A systematic review was conducted of eligible studies published in PubMed, Scopus, Google Scholar, and Web of Science from January 1, 1950 to August 30, 2020. Peer-reviewed cross-sectional studies describing WNV infections in humans and animals were systematically reviewed. Heterogeneity was assessed using the Cochrane Q statistic. RESULTS Eighteen out of 432 available search output were eligible and included for this study. Of which 13 and 5 were WNV studies on humans and animals, respectively. Although 61.5% of the human studies had a low risk of bias, they all had high heterogeneity. The South West geopolitical zone of Nigeria had the highest pooled prevalence of anti-WNV immunoglobulin M (IgM; 7.8% in humans). The pooled seroprevalence of anti-WNV IgM and immunoglobulin G (IgG) was 7.1% (95% confidence interval [CI], 5.9 to 8.3) and 76.5% (95% CI, 74.0 to 78.8), respectively. The WNV RNA prevalence was 1.9% (95% CI, 1.4 to 2.9), while 14.3% (95% CI, 12.9 to 15.8) had WNV-neutralizing antibodies. In animals, the pooled seroprevalence of anti-WNV IgM and IgG was 90.3% (95% CI, 84.3 to 94.6) and 3.5% (95% CI, 1.9 to 5.8), respectively, while 20.0% (95% CI, 12.9 to 21.4) had WNV-neutralizing antibodies. Age (odds ratio [OR], 3.73; 95% CI, 1.87 to 7.45; p<0.001) and level of education (no formal education: OR, 4.31; 95% CI, 1.08 to 17.2; p<0.05; primary: OR, 7.29; 95% CI, 1.80 to 29.6; p<0.01) were significant risk factors for WNV IgM seropositivity in humans. CONCLUSIONS The findings of this study highlight the endemicity of WNV in animals and humans in Nigeria and underscore the need for the One Health prevention and control approach.
Collapse
Affiliation(s)
- Idris Nasir Abdullahi
- Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Ahmadu Bello University, Zaria, Nigeria
| | - Anthony Uchenna Emeribe
- Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, University of Calabar, Calabar, Nigeria
| | - Peter Elisha Ghamba
- WHO National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria
| | | | - Zakariyya Muhammad Bello
- Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Ahmadu Bello University, Zaria, Nigeria
| | - Bamidele Soji Oderinde
- Department of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Maiduguri, Maiduguri, Nigeria
| | - Samuel Ayobami Fasogbon
- Public Health In-vitro Diagnostic Control Laboratory, Medical Laboratory Science Council of Nigeria, Lagos, Nigeria
| | - Lawal Olayemi
- Department of Medicine, National University of Samoa, Samoa
| | - Isa Muhammad Daneji
- Department of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria
| | - Muhammad Hamis Musa
- Department of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria
| | | | | | - Chukwudi Crescent Okume
- Department of Medical Laboratory Service, University of Nigeria Teaching Hospital, Enugu, Nigeria
| | - Sanusi Musa
- Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Ahmadu Bello University, Zaria, Nigeria
| | | | | |
Collapse
|
2
|
Kolawole OM, Adelaiye G, Ogah JI. Emergence and Associated Risk Factors of Vector Borne West Nile Virus Infection in Ilorin, Nigeria. J Arthropod Borne Dis 2018; 12:341-350. [PMID: 30918903 PMCID: PMC6423457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2016] [Accepted: 08/05/2018] [Indexed: 12/01/2022] Open
Abstract
BACKGROUND West Nile Virus (WNV) is a mosquito-borne viral pathogen that is the causative agent of West Nile fever and encephalitis. Diagnostic tools for WNV infection in Nigeria are not well established hence the current prevalence rate of WNV infection in Nigeria is unknown. We aimed to establish the serological prevalence of WNV infection in febrile patients in Ilorin, Nigeria in 2016, and to assess the risk factors associated with the acquisition of the virus. METHODS This was a cross-sectional study involving the screening of subjects presenting with febrile illnesses. While specific IgM ELISA was used to determine the seroprevalence, a closed-ended questionnaire was used to ascertain the risk factors associated with this viral infection. RESULTS Fifteen (7.5%) of the respondents were positive for WNV infection. Subjects living in areas in close proximity to trees and bushes (P= 0.011) and stagnant water (P= 0.001) were at a higher risk of having WNV infection. Other risk factors associated with WNV among the respondents include the none use of insecticide (P= 0.001), sitting out at night (P= 0.044), HIV positivity (P= 0.003) and having an organ transplant (P= 0.002). CONCLUSION This study clearly shows a considerable WNV infection in Ilorin, with the presence of factors that can promulgate an outbreak, hence a need for further surveillance in the study area.
Collapse
|